Hawrilenko Matt, Smolka Casey, Ward Emily, Kavelaars RuthAnne, Brown Millard, Chekroud Adam M
Spring Health, New York, NY, USA.
Department of Psychiatry Yale University School of Medicine, New Haven, Connecticut, USA.
J Health Econ Outcomes Res. 2025 Jun 20;12(1):246-251. doi: 10.36469/001c.138634. eCollection 2025.
The return on investment (ROI) of mental health care is a critical metric in an era of cost-conscious healthcare decision-making. However, selective reporting of positive study results may inflate ROI estimates. To quantify the mean and variation in employer-level ROI outcomes for a comprehensive behavioral health benefit program. Data were obtained from 19 employer-specific studies conducted between May 2023 and December 2024. Sources included medical claims data spanning 12 months pre- and post-program launch, and program billing records of clinical and nonclinical costs. Studies were included if they were conducted by a single behavioral health benefit where the full sample of studies was known. The population included 19 US employers where employees and dependents received up to 12 free psychotherapy or medication management sessions. All studies used the same inclusion and exclusion criteria, retrospective matched cohort design, and difference-in-differences analysis. Data were abstracted following PRISMA guidelines. ROI was estimated using a difference-in-differences model to control for baseline medical spending and pooled using inverse variance weighting with a random effects structure. The primary outcome was the ROI multiple, defined as the ratio of gross per-member-per-month savings to total program spending. The meta-analysis included 42 148 participants (14 645 program users and 27 503 matched controls) across a range of employer sizes and industries. The pooled ROI multiple was 2.3 (95% CI, 1.9-2.8), corresponding to net savings of 111-$207). Significant heterogeneity was observed (I² = 67.8%; t² = 0.646; < .001). A sensitivity analysis including nonclinical costs yielded a pooled ROI of 1.8. This meta-analysis, the largest of its kind, demonstrates that a centralized behavioral health benefit can consistently generate net savings across varied employer settings. These findings provide robust evidence to support the adoption of comprehensive mental health programs as an effective strategy for reducing overall medical spending in employer-sponsored health plans.
在医疗保健决策注重成本的时代,心理健康护理的投资回报率(ROI)是一个关键指标。然而,对积极研究结果的选择性报告可能会夸大ROI估计值。为了量化一个全面的行为健康福利计划在雇主层面的ROI结果的均值和变化情况。数据来自于2023年5月至2024年12月期间进行的19项针对特定雇主的研究。数据来源包括项目启动前12个月和后12个月的医疗理赔数据,以及临床和非临床成本的项目计费记录。如果研究是由单一行为健康福利进行的,且已知研究的完整样本,则纳入研究。研究对象包括19家美国雇主,其员工和家属可享受多达12次免费心理治疗或药物管理疗程。所有研究都采用相同的纳入和排除标准、回顾性匹配队列设计以及差异分析。数据按照PRISMA指南进行提取。使用差异模型估计ROI,以控制基线医疗支出,并采用具有随机效应结构的逆方差加权进行汇总。主要结果是ROI倍数,定义为每月每位成员的总节省与项目总支出的比率。荟萃分析涵盖了42148名参与者(14645名项目使用者和27503名匹配对照),涉及一系列雇主规模和行业。汇总的ROI倍数为2.3(95%CI,1.9 - 2.8),相当于净节省111 - 207美元。观察到显著的异质性(I² = 67.8%;t² = 0.646;P <.001)。纳入非临床成本的敏感性分析得出汇总的ROI为1.8。这项同类研究中规模最大的荟萃分析表明,集中式行为健康福利能够在不同的雇主环境中持续产生净节省。这些发现提供了有力证据,支持采用全面心理健康计划作为雇主赞助健康计划中降低总体医疗支出的有效策略。